MrsKristie Dickson
Research Associate
Discipline of Medical Science
Orcid identifier0000-0001-7307-8982 (opens in a new tab)
- Research AssociateDiscipline of Medical Science
BIO
Kristie Dickson is a cell and molecular biologist working in the Translational Oncology Group at UTS in the School of Life Sciences (SoLS), Faculty of Science.
She was awarded a Bachelor Science (Honours) in Biological/Biomedical Sciences from UTS in 1998. After completing her studies Kristie worked as a Research Assistant at the Department of Physiology at the University of Sydney investigating the regulation of ion transport in kidney epithelium using yeast-2-hybrid models. In 2000 she moved to the Kolling Institute of Medical Research at Royal North Shore Hospital to study the effects of Insulin-Like Binding Proteins (IGFBPs) on models of breast cancer. In 2003 she left academic research to work as a research scientist for the then start-up Biotechnology Company EnGeneIC Pty Ltd. Here she worked on a novel drug delivery system that targets cancer cells and her contributions led to a seminal paper published in Cancer Cell in 2007.
In 2007 she joined Professor Deborah Marsh’s laboratory at the Kolling Institute of Medical Research, to work on malignancies that affect women, with a focus on ovarian cancer, investigating chemoresistance, new therapies and epigenomic regulation. She moved to UTS with Professor Marsh in 2018 to continue this research.
Current Memberships
- Australia New Zealand Gynaecological Oncology Group (ANZGOG, 2015 -)
She was awarded a Bachelor Science (Honours) in Biological/Biomedical Sciences from UTS in 1998. After completing her studies Kristie worked as a Research Assistant at the Department of Physiology at the University of Sydney investigating the regulation of ion transport in kidney epithelium using yeast-2-hybrid models. In 2000 she moved to the Kolling Institute of Medical Research at Royal North Shore Hospital to study the effects of Insulin-Like Binding Proteins (IGFBPs) on models of breast cancer. In 2003 she left academic research to work as a research scientist for the then start-up Biotechnology Company EnGeneIC Pty Ltd. Here she worked on a novel drug delivery system that targets cancer cells and her contributions led to a seminal paper published in Cancer Cell in 2007.
In 2007 she joined Professor Deborah Marsh’s laboratory at the Kolling Institute of Medical Research, to work on malignancies that affect women, with a focus on ovarian cancer, investigating chemoresistance, new therapies and epigenomic regulation. She moved to UTS with Professor Marsh in 2018 to continue this research.
Current Memberships
- Australia New Zealand Gynaecological Oncology Group (ANZGOG, 2015 -)
PROFILE TYPE
- Academic